Former 510(k) Staff Director Takes Critical Look At FDA's Reform Plan
This article was originally published in The Gray Sheet
Executive Summary
As FDA rolls out changes to its 510(k) review process, Heather Rosecrans, former director of the 510(k) program staff, and now on the industry side of the debate, is watching with keen interest and some trepidation.